Search Results 1851-1860 of 16333 for monoclonal antibody

  1. A Study to Evaluate Feasibility of In Vivo Sensitivity Screen Using Direct Tumor Microinjection and FDG-PET in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer - Mayo Clinic

    Therapeutic anticancer antibodies ≤ 2 weeks prior to registration;; Radio- or toxin immunoconjugates ≤ 4 weeks prior to registration;; Radiation therapy to ...

  2. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

    Known history of human immunodeficiency virus (HIV) (HIV 1/2 antibodies); Known active hepatitis B or hepatitis C; Active autoimmune disease that has required ...

  3. A Study to Investigate FE 999049 in the Treatment of Infertility in Women Aged 18-34 Years Old with Assisted Reproductive Technology - Mayo Clinic

    Negative serum Hepatitis B Surface Antigen (HBsAg), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) antibody tests at screening or within 6 ...

  4. Research - Family Study of CLL and Other Lymphoproliferative Disorders

    Epidemiology of Monoclonal B-Cell Lymphocytosis Study · Resources · Contact. Family Study of CLL and Other Lymphoproliferative Disorders. The Family Study of ...

  5. Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps - Mayo Clinic

    Antinuclear antibody (ANA) test result excludes overt autoimmune disease; note: test result may be reported in any of the following formats: =< 1:160, negative, ...

  6. Mayo Clinic Q & A - Dr. Gregory Poland - YouTube Audio - 3 2...

    The report came out today of a research group that identified an antibody, and it's called a platelet four factor antibody, a similar antibody to what us as ...

  7. Neoadjuvant Pembrolizumab - Mayo Clinic

    Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies). Has active autoimmune disease that has required systemic treatment in the ...

  8. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

    an anti-CD20 antibody-containing regimen; a chlorambucil-containing regimen; an alemtuzumab-containing regimen (for those subjects with a 17p deletion). Must ...

  9. Study of INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma - Mayo Clinic

    History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins;; Known hypersensitivity ...

  10. Dr. Svetomir Markovic Archives - Mayo Clinic News Network

    Kaposi sarcoma. Bispecific antibodies. When the immune system detects cancer cells or other abnormal cells, it produces immune cells called antibodies to attack ...